Has Brian Williams, MD received payments from drug or device companies?

Yes. Drug and device makers reported $875,933 in general payments to Brian Williams, MD across 1,551 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Brian Williams, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Brian Williams, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Brian Williams, MD

Dermatology · Midvale, UTNPI 1235162199

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $749,225 of the $875,933 with a category attached, or 85.5%. 26 manufacturers reported payments, led by Galderma Laboratories, L.p. at 28.6% of the total. 2025 is the largest year on record at $307,733, 3.5 times the $87,013 reported in 2019. Among dermatology clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$875,933in general payments, 2019–2025

Across 1,551 payments — averaging $564.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Galderma Laboratories, L.p.$251K
Lilly USA, LLC$225K
Dermavant Sciences, Inc.$90K
UCB, Inc.$79K
LEO Pharma Inc.$58K
Pfizer$54K
plus $120K from 20 others

What the payments were for

Consulting fees$39,4385%
Speaking & faculty fees$749,22586%
Grants$440%
Travel & lodging$66,8118%
Food & beverage$20,2652%
Education$1490%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Galderma Laboratories, L.p.	354	$250,954
Lilly USA, LLC	346	$224,910
Dermavant Sciences, Inc.	92	$89,657
UCB, Inc.	141	$78,532
LEO Pharma Inc.	97	$57,630
Pfizer	113	$54,238
Incyte Corporation	83	$45,557
Organon	34	$32,614
Novartis	89	$28,689
Dermira, Inc.	15	$10,116
AbbVie	93	$1,136
E.r. Squibb & Sons, L.L.C.	16	$341
Sanofi	16	$310
Johnson & Johnson	10	$288
Ortho Dermatologics, A Division Of Bausch Health US, LLC	12	$278
Regeneron Healthcare Solutions, Inc.	8	$176
Sun Pharmaceutical Industries Inc.	5	$77
Amgen	4	$77
Sanofi-aventis U.S. LLC	3	$61
Arcutis Biotherapeutics, Inc.	3	$58
Almirall LLC	2	$56
Prugen, Inc. Pharmaceuticals	8	$55
VYNE Pharmaceuticals Inc.	2	$44
Botanix SB Inc	2	$35
Mylan Pharmaceuticals Inc.	2	$28
EPI Health, LLC	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

VTAMA$120,485
EBGLYSS$90,440
AKLIEF$88,946
NEMLUVIO$82,723
OLUMIANT$75,824
Bimzelx$75,192
ADBRY$50,542
EPIDUO FORTE$44,103
OPZELURA$39,513
TALTZ$38,439
CIBINQO$26,833
EUCRISA$26,108
COSENTYX$25,288
TWYNEO$24,566
ORACEA$17,235
EPSOLAY$17,235
ANZUPGO$9,998
QBREXZA$9,911
SILIQ$118
DUOBRII$118

How this compares

$875,933 in reported general payments places this provider in the 95th percentile of 163 dermatology providers in Utah.

See all dermatology providers in Utah →

Medicare billing

Part B allowed, 2024

$81,590

Medicare patients

638

Services billed

1,151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Fluorouracil	146	$10,337
Tacrolimus	85	$8,083
Betamethasone Dipropionate	87	$3,821
Ketoconazole	155	$2,052
Fluocinolone AcetonideFluocinolone/Shower Cap	33	$1,877
Clindamycin Phosphate	54	$1,377
Doxycycline Hyclate	47	$1,352
Tretinoin	14	$1,336
Econazole Nitrate	54	$1,258
Triamcinolone Acetonide	142	$1,149
Metronidazole	17	$922
Fluocinonide	22	$651
Minoxidil	65	$613
Terbinafine Hcl	40	$589
Famciclovir	19	$456

Paid to pharmacies, not to this prescriber.

Other dermatology in Midvale

Kirk StephensMidvale$5K
Joseph JensenMidvale$4K
Travis JamesProvidence$437K
Jason HadleyBountiful$294K
Doug Lass ForshaWest Jordan$213K
Gerald KruegerSalt Lake City$156K
Jamie RhoadsMurray$105K
Kristina DuffinSalt Lake City$89K
Mark TaylorSalt Lake City$58K
Lori RamirezKaysville$38K

See the full list for Utah →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →